Comparison of the effects between escitalopram and venlafaxine on the social function in patients with depression
Qi Li
Abstract
Qi Li
Abstract
Objective To compare the effects of escitalopram and venlafaxine on the social function in patients with depression. Methods A total of 100 patients who met the diagnostic criteria of depression were randomly divided into two groups and treated with escitalopram and venlafaxine respectively. The therapeutic efficacy was measured with Hamilton depression scale(HAM D-17); the improvement of social function was measured with Sheehan disability scale(SDS) and the short form-36 health survey(SF-36). The side effects were evaluated by the treatment emergent symptom scale(TESS). Results There were no significant differences in the HAM D scores between the two groups at each interviewtime(P 0. 05),but the scores of HAM D in both groups decreased significantly compared with the baseline(P 0. 01). There were no significant differences in the effective rate and remission rate after 8 weeks of treatment between the two groups(P 0. 05). There were marked differences in scores of SDS and social functions factor scores of SF-36 at the end of the 8th week and the baseline in both groups(P 0. 01),but no significant differences before treatment and after 8 weeks of therapy(P 0. 05). Conclusion Both escitalopram and venlafaxine can effectively improve the social function in patients with depression,with no statistically significant differences between them.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the effects of escitalopram and venlafaxine on the social function in patients with depression. Methods A total of 100 patients who met the diagnostic criteria of depression were randomly divided into two groups and treated with escitalopram and venlafaxine respectively. The therapeutic efficacy was measured with Hamilton depression scale(HAM D-17); the improvement of social function was measured with Sheehan disability scale(SDS) and the short form-36 health survey(SF-36). The side effects were evaluated by the treatment emergent symptom scale(TESS). Results There were no significant differences in the HAM D scores between the two groups at each interviewtime(P 0. 05),but the scores of HAM D in both groups decreased significantly compared with the baseline(P 0. 01). There were no significant differences in the effective rate and remission rate after 8 weeks of treatment between the two groups(P 0. 05). There were marked differences in scores of SDS and social functions factor scores of SF-36 at the end of the 8th week and the baseline in both groups(P 0. 01),but no significant differences before treatment and after 8 weeks of therapy(P 0. 05). Conclusion Both escitalopram and venlafaxine can effectively improve the social function in patients with depression,with no statistically significant differences between them.
Key concepts: Escitalopram, Venlafaxine, Depression (economics), Internal medicine, Hamilton depression scale, Citalopram, Psychology, Medicine